Alzheimer’s disease (AD), the most common form of dementia, is characterized by amyloid beta and Tau protein plaques. Unfortunately, there is no permanent cure for AD. FDA-approved drugs like cholinesterase inhibitors, NMDA receptor antagonists, and immunotherapies offer temporary relief but can’t reverse neuron damage.
Researchers worldwide are working tirelessly to identify new treatment targets and innovative therapies. Among these, stem cell therapy stands out. Stem cells possess the unique ability to differentiate into different cell types, making them a promising avenue for AD treatment. Pre-clinical studies have shown encouraging results, but more advancements are needed to bring this therapy to a practical level.
Over the past decade, extensive research has generated numerous hypotheses regarding AD pathology. In addition, there have been significant strides in therapeutic strategies, including immunotherapy and stem cell therapy. These promising treatments are currently undergoing clinical trials, offering hope to those affected by AD.
While a definitive cure for AD remains elusive, ongoing research and innovative treatments provide a glimmer of hope for the future.
Please always speak to your doctor if you have any health issues.
